$150,000 Commitment in Support of 20th Annual Benefit and ‘Taking Flight’ Research Award
This pilot randomized, parallel-group, controlled trial comparing the GoToSleep program and controls on change in Insomnia Severity Index (ISI) from baseline to week 8 in adults with epilepsy and moderate-to-severe insomnia.
New guidelines highlight the evidence supporting the use of certain anti-epileptic drugs for reducing the frequency of seizures in new-onset focal epilepsy and treatment-resistant epilepsy.
Genetics
Scientists report developing high-tech tools to uncover the genetic cause of early infantile epileptic encephalopathy (EIEE).
The underlying pathogenesis of new-onset seizures or epilepsy in recipients of transplantation needs to be further elucidated. In addition, more information is required from prospective studies and research focusing on therapeutic strategies.
